2nd Annual Conference on Precision Psychiatry: Innovation to Implementation

November 2, 2022 to November 3, 2022

The Annual Conference on Precision Psychiatry, hosted by the MGH Center for Precision Psychiatry, is becoming a leading venue for showcasing advances in the application of precision medicine approaches to psychiatric research and clinical practice. Our Keynote Speakers will be Dr. Kelsey Martin, Director of the Simons Foundation Autism Research Initiative (SFARI), and Dr. Thomas Insel, former Director of NIMH and author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022). The Conference will be held virtually over the course of two days: Wednesday, November 2nd and Thursday, November 3rd, 2022. The Conference is designed to cover a broad range of domains including:

  • Applications of AI & machine learning in psychiatry
  • Genomics and other omics
  • Precision therapeutics
  • Risk stratification for suicide and other important outcomes
  • mHealth and digital technologies
  • Implementation science
  • Ethics and equity

Pricing

All Registrants: $200.00

Course summary
Registration opens: 
06/20/2022
Course closes: 
11/03/2022
Event starts: 
11/02/2022 - 1:00pm EDT
Event ends: 
11/03/2022 - 2:00pm EDT
Cost:
$200.00
Rating: 
0

Second Annual Conference on Precision Psychiatry Wednesday November 2, 2022 - Thursday, November 3, 2022 AGENDA

 

DAY ONE: Wednesday November 2, 2022 (1:00 PM - 5:30 PM EDT)

Time

Content

Speaker

1:00pm-1:10pm

Welcome Remarks

JORDAN W. SMOLLER, MD, ScD & MAURIZIO FAVA, MD

1:10pm-1:40pm

Conference Keynote: Presentation title TBD

THOMAS INSEL, MD

Author of Healing: Our Path from Mental Illness to Mental Health; Former NIMH Director

1:40pm-2:00pm

Moderated Discussion/Q&A: THOMAS INSEL, MD

Moderator: JORDAN W. SMOLLER, MD

2:00pm-3:30pm

Leveraging Healthcare Data for Precision Medicine Session Chair: TBD

2:00pm-2:30pm

Presentation title TBD

LEA DAVIS, PhD

Associate Professor Of Medicine, Vanderbilt University Medical Center

2:30pm-3:00pm

Presentation title TBD

NIGAM SHAH, PhD

Chief Data Scientist, Stanford Healthcare

3:00pm-3:30pm

Moderated Discussion/Q&A: LEA DAVIS, PhD & NIGAM SHAH, PhD

Moderator: TBD

3:30pm-3:50pm

BREAK

3:50pm-4:20pm

Data & Prediction: The Role of Academia and Industry in Advancing Precision Psychiatry

Moderator: TBD

3:50pm-4:20pm

Panel

OLIVER HARRISON, MA, MPH

Chief Executive Officer, Koa Health

 

SCOTT KOLLINS, PhD

Chief Medical Officer, Holmusk

4:20pm-5:20pm

Precision Treatment Stratification and Pharmacogenetics Session Chair: TBD

4:20pm-4:50pm

Presentation title TBD

CHAD BOUSMAN, PhD

CEO/Founder, Sequence2Script; Associate Professor, University of Calgary

 

4:50pm-5:20pm

Presentation title TBD

CATHRYN LEWIS, PhD

Head of Department of Social, Genetic and Developmental Psychiatry Centre, King’s College London

5:20pm-5:30pm

Closing Remarks

JORDAN W. SMOLLER, MD, ScD

 

 

 

DAY TWO: Thursday, November 3, 2022 (9:00 AM - 2:00 PM EDT)

Time

Content

Speaker

9:00am-9:10am

Welcome Remarks

JORDAN W. SMOLLER, MD, ScD

9:10am-9:40am

Conference Keynote: Presentation title TBD

KELSEY MARTIN, MD, PhD

Director of SFARI, Simons Foundation

9:40am-10:00am

Moderated Discussion/Q&A: KELSEY MARTIN, MD, PhD

Moderator: TBD

10:00am-11:00am

Methods and Tools Session Chair: TBD

10:00am-10:30am

Presentation title TBD

ANTHONY PHILIPPAKIS, MD, PhD

Chief Data Officer, Broad Institute of MIT and Harvard; Venture Partner, GV

10:30am-11:00am

Presentation title TBD

LAURA GERMINE, PhD

Director of Brain and Cognitive Health Technology, McLean Hospital; Assistant Professor, Harvard Medical School

11:00am-12:00pm

Precision Neuroscience & Novel Therapeutics Session Chair: TBD

11:00am-11:30am

Presentation title TBD

STEPHEN HAGGARTY, PhD

Associate Professor, Harvard Medical School

11:30am-12:00pm

Presentation title TBD

YASMIN HURD, PhD

Director of the Addiction Institute, Icahn School of Medicine Mount Sinai

12:00pm-12:20pm

BREAK

12:20pm-12:50pm

Therapeutics: The Role of Academia and Industry in Advancing Precision Psychiatry

Moderator: TBD

 

12:20pm-12:50pm

Panel

JENNY BARNETT, PhD

Chief Executive Officer, Monument Therapeutics

 

DAVID OLSON, PhD

Chief Innovation Officer, Delix Therapeutics

 

MORGAN SHENG, PhD

Core Institute Member and Co-Director of Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard

12:50pm-1:50pm

Genomic Medicine Session Chair: TBD

12:50pm-1:20pm

Presentation title TBD

WENDY CHUNG, MD, PhD

Kennedy Family Professor of Pediatrics and Medicine, Columbia University

1:20pm-1:50pm

Presentation title TBD

JEHANNINE AUSTIN, PhD, MSc

Professor, University of British Columbia

1:50pm-2:00pm

Closing Remarks

JORDAN W. SMOLLER, MD, ScD

KEYNOTE SPEAKERS

Thomas Insel, MD - Former Director of NIMH; Author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022) 
Kelsey Martin, PhD - Director of the Simons Foundation Autism Research Initiative (SFARI)
 

SPEAKERS

Jehannine Austin, PhD - Professor, University of British Columbia
Jennifer Barnett, PhD - Chief Executive Officer, Monument Therapeutics
Chad Bousman, PhD - Associate Professor, University of Calgary
Wendy Chung, MD, PhD - Kennedy Family Professor of Pediatrics and Medicine, Columbia University
Lea Davis, PhD - Assistant Professor of Medicine, Biomedical Informatic, Molecular Physiology & Biophysics, and Psychiatry & Behavioral Sciences, Vanderbilt University Medical Center
Laura Germine, PhD - Director of Brain and Cognitive Health Technology, McLean Hospital
Stephen Haggarty, PhD - Associate Professor, Harvard Medical School Oliver Harrison, MA, MPH - Chief Executive Officer, Koa Health
Yasmin Hurd, PhD - Director of the Addiction Institute, Mount Sinai
Scott Kollins, PhD - Chief Medical Officer, Holmusk
Cathryn Lewis, PhD - Professor of Genetic Epidemiology & Statistics, & Head of Department, Social, Genetic & Developmental Psychiatry Centre, King's College London
David Olson, PhD - Chief Innovation Officer, Delix Therapeutics
Anthony Philippakis, MD, PhD - Chief Data Officer, Broad Institute of MIT and Harvard
Nigam Shah, PhD - Professor of Medicine, Stanford University
Morgan Sheng, PhD - Core Institute Member and Co-Director of Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard

Price

Cost:
$200.00
Please login or register to take this course.

COURSE DIRECTORS/PLANNERS

Jordan Smoller, MD, ScD – Director, MGH Center for Precision Psychiatry; Director, MGH Psychiatric and Neurodevelopmental Genetics Unit; Professor of Psychiatry, Harvard Medical School; Professor in Epidemiology, T.H. Chan Harvard School of Public Health

Megan Candito, MA – Marketing and Administrative Coordinator, MGH Center for Precision Psychiatry

Karmel Choi, PhD – Director, Precision Prevention Program at MGH Center for Precision Psychiatry; Clinical Psychologist at MGH; Assistant Professor at Harvard Medical School

Maurizio Fava, MD – Psychiatrist-in-Chief, MGH; Vice Chair, MGH Executive Committee of Research

Roy Perlis, MD - Associate Chief (Research), MGH Department of Psychiatry; Director, MGH Center for Quantitative Health; Director, MGH Center for Experimental Drugs and Diagnostics; Ronald I. Dozoretz, MD Endowed Professor of Psychiatry, Harvard Medical School

Jerrold Rosenbaum, MD – Director, MGH Center for the Neuroscience of Psychedelics; Stanley Cobb Professor of Psychiatry, Harvard Medical School; Co-Founder and Director, Psy Therapeutics, Inc; Co-Founder, Sensorium Therapeutics

Ashley Seiger, MSc – Program Director, MGH Center for Precision Psychiatry

Sabine Wilhelm, PhD – Director, MGH Center for Digital Mental Health; Chief of Psychology, MGH; Director, MGH Center for OCD and Related Disorders; Professor, Harvard Medical School